Skip to Main Content

Paper Details

Characterizing the Therapeutic Potential of a Potent BET Degrader in Merkel Cell Carcinoma.
Neoplasia
5
2019
+ MCC cells, BET, BET proteins, BETd, BETd-246, HOX, HOX and, LT Ag, MCC, MCC cell lines, MCC lineage, MCC signature" genes, MCPyV, MCPyV+ MCC cells, MCPyV- MCC cell lines, MYC, Merkel, Merkel Cell Carcinoma, Merkel cell carcinoma, Merkel cell polyomavirus, cell cycle genes
Author NameAffiliation
Xuhong CaoMichigan Center for Translational Pathology, University of Michigan ann arbor
Marcin CieslikMichigan Center for Translational Pathology, University of Michigan ann arbor
Arul M ChinnaiyanMichigan Center for Translational Pathology, University of Michigan, USA Rogel Cancer Center, USA Howard Hughes Medical Institute ann arbor
Arul M ChinnaiyanMichigan Center for Translational Pathology, University of Michigan, USA Rogel Cancer Center, USA Howard Hughes Medical Institute ann arbor
  • 1 - 4

Datasets

Release 1.2